Idiopathic calcium nephrolithiasis: A review of pathogenic mechanisms in the light of genetic studies

American Journal of Nephrology

Volumn 40, Issue 6, 2014, Pages 499-506

  Arcidiacono, Teresa ^a   Mingione, Alessandra ^b   Macrina, Lorenza ^a   Pivari, Francesca ^b   Soldati, Laura ^b   Vezzoli, Giuseppe ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Calcium excretion; Calcium kidney stones; Genetic polymorphism; Phosphate excretion; Randall's plaque

Indexed keywords

CALCIUM OXALATE; CALCIUM PHOSPHATE; HYDROXYAPATITE; AQP1 PROTEIN, HUMAN; AQUAPORIN 1; CALCITRIOL RECEPTOR; CALCIUM BINDING PROTEIN; CALCIUM SENSING RECEPTOR; CASR PROTEIN, HUMAN; CLAUDIN; CLAUDIN 14; DIACYLGLYCEROL KINASE; MATRIX GLA PROTEIN; OSTEOPONTIN; SCLEROPROTEIN; SLC34A1 PROTEIN, HUMAN; SLC34A3 PROTEIN, HUMAN; SODIUM PHOSPHATE COTRANSPORTER 2A; SODIUM PHOSPHATE COTRANSPORTER 2C; TAMM HORSFALL GLYCOPROTEIN; UMOD PROTEIN, HUMAN; UROKINASE; VDR PROTEIN, HUMAN;

CALCIUM STONE; ENDOSCOPY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HUMAN; IDIOPATHIC CALCIUM NEPHROLITHIASIS; KIDNEY INTERSTITIUM; KIDNEY PROXIMAL TUBULE; NEPHROLITHIASIS; PRIORITY JOURNAL; REVIEW; GENETICS; METABOLISM; SINGLE NUCLEOTIDE POLYMORPHISM;

AQUAPORIN 1; CALCIUM OXALATE; CALCIUM PHOSPHATES; CALCIUM-BINDING PROTEINS; CLAUDINS; DIACYLGLYCEROL KINASE; EXTRACELLULAR MATRIX PROTEINS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; NEPHROLITHIASIS; OSTEOPONTIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCITRIOL; RECEPTORS, CALCIUM-SENSING; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE IIA; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE IIC; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; UROMODULIN;

EID: 84917694792     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000369833     Document Type: Review

References (67)

1. Croppi E, Ferraro PM, Taddei L, Gambaro G: Prevalence of renal stones in an Italian urban population: a general practice-based study. Urol Res 2012; 40: 517-522.
2. Goldfarb DS, Fischer ME, Keich Y, Goldberg J: A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry. Kidney Int 2005; 67: 1053-1061.
3. Resnick M, Pridgen DB, Goodman HO: Genetic predisposition to formation of calcium oxalate renal calculi. N Engl J Med 1968; 278: 1313-1318.
4. Evan AP, Lingeman JE, Coe FL, et al: Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 2003; 111: 607-616.
5. Tiselius HG: A hypothesis of calcium stone formation: an interpretation of stone research during the past decades. Urol Res 2011; 39: 231-243.
6. Evan AP, Coe FL, Lingeman JE, et al: Mechanism of formation of human calcium oxalate renal stones on Randall's plaque. Anat Rec 2007; 290: 1315-1323.
7. Evan A, Lingeman J, Coe FL, Worcester E: Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int 2006; 69: 1313-1318.
8. Tiselius HG: The role of calcium phosphate in the development of Randall's plaques. Urolithiasis 2013; 41: 369-377.
9. Stoller ML, Low RK, Shami GS, et al: High resolution radiography of cadaveric kidneys: unraveling the mystery of Randall's plaque formation. J Urol 1996; 156: 1263-1266.
10. Stoller ML, Meng MV, Abrahams HM, Kane JP: The primary stone event: a new hypothesis involving a vascular etiology. J Urol 2004; 171: 1920-1924.
11. Koleganova N, Piecha G, Ritz E, Schmitt CP, Gross ML: A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia. Kidney Int 2009; 75: 60-71.
12. Jono S, McKee MD, Murry CE, et al: Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000; 87:E10-E17.
13. Sage AP, Lu J, Tintut Y, Demer LL: Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int 2011; 79: 414-422.
14. Henaut L, Boudot C, Massy ZA, et al: Calcimimetics increase CaSR expression and reduce mineralization in vascular smooth muscle cells: mechanisms of action. Cardiovasc Res 2014; 101: 256-265.
15. Aoshima Y, Mizobuchi M, Ogata H, et al: Vitamin D receptor activators inhibit vascular smooth muscle cell mineralization induced by phosphate and TNF. Nephrol Dial Transplant 2012; 27: 1800-1806.
16. Jia Z, Wang S, Tang J, et al: Does crystal deposition in genetic hypercalciuric rat kidney tissue share similarities with bone formation Urology 2014; 83: 509.e7-509.e14.
17. Merchant ML, Cummins TD, Wilkey DW, et al: Proteomic analysis of renal calculi indicates an important role for inflammatory processes in calcium stone formation. Am J Physiol Renal Physiol 2008; 295:F1254-F1258.
18. Ryall RL, Harnett RM, Hibberd CM, Edyvane KA, Marshall VR: Effects of chondroitin sulphate, human serum albumin and Tamm-Horsfall mucoprotein on calcium oxalate crystallization in undiluted human urine. Urol Res 1991; 19: 181-188.
19. Thorleifsson G, Holm H, Edvardsson V, et al: Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat Genet 2009; 412: 926-930.
20. Angelow S, Ahlstrom R, Yu AS: Biology of claudins. Am J Physiol Renal Physiol 2008; 295:F867-F876.
21. Ben-Yosef T, Belyantseva IA, Saunders TL, et al: Claudin 14 knockout mice, a model for autosomal recessive deafness DFNB29, are deaf due to cochlear hair cell degeneration. Hum Mol Genet 2003; 12: 2049-2061.
22. Gong Y, Renigunta V, Himmerkus N, et al: Claudin-14 regulates renal Ca ++ transport in response to CaSR signaling via a novel microRNA pathway. EMBO J 2012; 31: 1999-2012.
23. Toka HR, Al-Romaih K, Koshy JM, et al: Deficiency of the calcium-sensing receptor in the kidney causes parathyroid hormone-independent hypocalciuria. J Am Soc Nephrol 2012; 23: 1879-1890.
24. Dimke H, Desai P, Borovac J, Lau A, Pan W, Alexander RT: Activation of the Ca(2+)-sensing receptor increases renal claudin-14 expression and urinary Ca(2+) excretion. Am J Physiol Renal Physiol 2013; 304:F761-F769.
25. Gong Y, Hou J: Claudin-14 underlies Ca ++-sensing receptor-mediated Ca ++ metabolism via NFAT-microRNA-based mechanisms. J Am Soc Nephrol 2014; 25: 745-760.
26. Vezzoli G, Terranegra A, Arcidiacono T, et al: Calcium kidney stones are associated with a haplotype of the calcium-sensing receptor gene regulatory region. Nephrol Dial Transplant 2010; 25: 2245-2252.
27. Vezzoli G, Scillitani A, Corbetta S, et al: Polymorphisms at the regulatory regions of the CASR gene influence stone risk in primary hyperparathyroidism. Eur J Endocrinol 2011; 164: 421-427.
28. Vezzoli G, Terranegra A, Aloia A, et al. Decreased transcriptional activity of calciumsensing receptor gene promoter 1 is associated with calcium nephrolithiasis. J Clin Endocrinol Metab 2013; 98: 3839-3847.
29. Brown EM, MacLeod RJ: Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 2001; 81: 239-297.
30. Blankenship KA, Williams JJ, Lawrence MS, McLeish KR, Dean WL, Arthur JM: The calcium-sensing receptor regulates calcium absorption in MDCK cells by inhibition of PMCA. Am J Physiol Renal Physiol 2001; 280:F815-F822.
31. Sands JM, Naruse M, Baum M, et al: Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J Clin Invest 1997; 99: 1399-1405.
32. Casare F, Milan D, Fernandez R: Stimulation of calcium-sensing receptor increases biochemical H +-ATPase activity in mouse cortex and outer medullary regions. Can J Physiol Pharmacol 2014; 92: 181-188.
33. Capasso G, Geibel PJ, Damiano S, Jaeger P, Richards WG, Geibel JP: The calcium sensing receptor modulates fluid reabsorption and acid secretion in the proximal tubule. Kidney Int 2013; 84: 277-284.
34. Urabe Y, Tanikawa C, Takahashi A, Okada Y, et al: A genome-wide association study of nephrolithiasis in the Japanese population identifies novel susceptible Loci at 5q35.3, 7p14.3, and 13q14.1. PLoS Genet 2012; 8:e1002541.
35. Lapointe JY, Tessier J, Paquette Y, et al: NPT2a gene variation in calcium nephrolithiasis with renal phosphate leak. Kidney Int 2006; 69: 2261-2267.
36. Chau H, El-Maadawy S, McKee MD, Tenenhouse HS: Renal calcification in mice homozygous for the disrupted type IIa Na/Pi cotransporter gene Npt2. J Bone Miner Res 2003; 18: 644-657.
37. Prie D, Huart V, Bakouh N, et al: Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter. N Engl J Med 2002; 347: 983-991.
38. Prie D, Ravery V, Boccon-Gibod L, Friedlander G: Frequency of renal phosphate leak among patients with calcium nephrolithiasis. Kidney Int 2001; 60: 272-276.
39. Wolf MT, Zalewski I, Martin FC, et al: Mapping a new suggestive gene locus for autosomal dominant nephrolithiasis to chromosome 9q33.2-q34.2 by total genome search for linkage. Nephrol Dial Transplant 2005; 20: 909-914.
40. Schnermann JB, Huang YG, Mizel D: Fluid reabsorption in proximal convoluted tubules of mice with gene deletions of claudin-2 and/ or aquaporin1. Am J Physiol Renal Physiol 2013; 305:F1352-F1364.
41. Ma T, Yang B, Gillespie A, Carlson EJ, Epstein CJ, Verkman AS: Severely impaired urinary concentrating ability in transgenic mice lacking aquaporin-1 water channels. J Biol Chem 1998; 273: 4296-4299.
42. Scott P, Ouimet D, Valiquette L, et al: Suggestive evidence for a susceptibility gene near the vitamin D receptor locus in idiopathic calcium stone formation. J Am Soc Nephrol 1999; 10: 1007-1013.
43. Mossetti G, Rendina D, Viceconti R, et al: The relationship of 3 vitamin D receptor haplotypes to urinary supersaturation of calcium oxalate salts and to age at onset and familial prevalence of nephrolithiasis. Nephrol Dial Transplant 2004; 19: 2259-2265.
44. Bid HK, Kumar A, Kapoor R, Mittal RD: Association of vitamin D receptor-gene (FokI) polymorphism with calcium oxalate nephrolithiasis. J Endourol 2005; 19: 111-115.
45. Morrison NA, Qi JC, Tokita A, et al: Prediction of bone density from vitamin D receptor alleles. Nature 1994; 367: 284-287.
46. Zhang P, Nie W, Jiang H: Effects of vitamin D receptor polymorphisms on urolithiasis risk: a meta-analysis. BMC Med Genet 2013; 14: 104.
47. Liu CC, Huang CH, Wu WJ, et al: Association of vitamin D receptor (Fok-I) polymorphism with the clinical presentation of calcium urolithiasis. BJU Int 2007; 99: 1534-1538.
48. Xi QL, Wang SG, Ye ZQ, Zhu ZW, Li C, Bai J, Yu X, Liu JH: Effect of silencing VDR gene in kidney on renal epithelial calcium transporter proteins and urinary calcium excretion in genetic hypercalciuric stone-forming rats. Urology 2011; 78: 1442.e1-1442.e7.
49. Frick KK, Asplin JR, Favus MJ, Culbertson C, Krieger NS, Bushinsky DA: Increased biological response to 1,25(OH)(2)D(3) in genetic hypercalciuric stone-forming rats. Am J Physiol Renal Physiol 2013; 304:F718-F726.
50. Suzuki Y, Pasch A, Bonny O, Mohaupt MG, Hediger MA, Frey FJ: Gain-of-function haplotype in the epithelial calcium channel TRPV6 is a risk factor for renal calcium stone formation. Hum Mol Genet 2008; 17: 1613-1618.
51. Gudbjartsson DF, Holm H, Indridason OS, et al: Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases. PLoS Genet 2010; 6:e1001039.
52. Santambrogio S, Cattaneo A, Bernascone I, et al: Urinary uromodulin carries an intact ZP domain generated by a conserved C-terminal proteolytic cleavage. Biochem Biophys Res Commun 2008; 370: 410-413.
53. Wolf MT, Wu XR, Huang CL: Uromodulin upregulates TRPV5 by impairing caveolin-mediated endocytosis. Kidney Int 2013; 84: 130-137.
54. Mutig K, Kahl T, Saritas T, et al: Activation of the bumetanide-sensitive Na+, K+, 2Cl-cotransporter (NKCC2) is facilitated by Tamm-Horsfall protein in a chloride-sensitive manner. J Biol Chem 2011; 286: 30200-30210.
55. Gao B, Yasui T, Itoh Y, et al: Association of osteopontin gene haplotypes with nephrolithiasis. Kidney Int 2007; 72: 592-598.
56. Liu CC, Huang SP, Tsai LY, et al: The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis. Clin Chim Acta 2010; 411: 739-743.
57. Xie Y, Sakatsume M, Nishi S, et al: Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int 2001; 60: 1645-1657.
58. Tsai FJ, Lin CC, Lu HF, Chen HY, Chen WC: Urokinase gene 3 UTR T/C polymorphism is associated with urolithiasis. Urology 2002; 59: 458-461.
59. Ozturk M, Kordan Y, Cangul H, et al: Association of urokinase gene 3 UTR T/C polymorphism with calcium oxalate urolithiasis in children. Int Urol Nephrol 2008; 40: 563-568.
60. Van Aswegen CH, Dirksen van Sckalckwyk JC, du Toit PJ, Verster L, Franz RC, du Plessis DJ: The effect of calcium and magnesium ions on urinary urokinase and sialidase activity. Urol Res 1992; 20: 41-44.
61. Mittal RD, Bid HK, Kumar A, et al: Association of urokinase gene 3 UTR polymorphism with calcium oxalate nephrolithiasis. J Endourol 2006; 20: 157-160.
62. Schurgers LJ, Barreto DV, Barreto FC, et al: The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report. Clin J Am Soc Nephrol 2010; 5: 568-575.
63. Gao B, Yasui T, Itoh Y, Tozawa K, Hayashi Y, Kohri K: A polymorphism of matrix Gla protein gene is associated with kidney stones. J Urol 2007; 177: 2361-2365.
64. Lu X, Gao B, Liu Z, et al: A polymorphism of matrix Gla protein gene is associated with kidney stone in the Chinese Han population. Gene 2012; 511: 127-130.
65. Goiko M, Dierolf J, Gleberzon JS, et al: Peptides of Matrix Gla protein inhibit nucleation and growth of hydroxyapatite and calcium oxalate monohydrate crystals. PLoS One 2013; 8:e80344.
66. Lian JB, Prien EL Jr, Glimcher MJ, Gallop PM: The presence of protein-bound gamma-carboxyglutamic acid in calcium-containing renal calculi. J Clin Invest 1977; 59: 1151-1157.
67. Zaidi SK, Young DW, Montecino MA, et al: Mitotic bookmarking of genes: a novel dimension to epigenetic control. Nat Rev Genet 2010; 11: 583-589.